May 8, 2017 / 3:50 AM / 3 months ago

BRIEF-MG Med to buy 17.1 pct stake in Oxford Cancer Biomarkers for 3.40 bln won

May 8 (Reuters) - MG Med Inc :

* Says it plans to buy 1,846 shares of Oxford Cancer Biomarkers Limited, a Scotland pharma firm, for 3.40 billion won

* Says it will hold 17.1 percent stake(1,846 shares) in target company after transaction

Source text in Korean: goo.gl/psTn6B

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below